These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4368493)

  • 21. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F
    Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of bilateral metastatic carcinoma of the uveal tract].
    Skosareva SK
    Vestn Oftalmol; 1967; 80(3):81-3. PubMed ID: 5615730
    [No Abstract]   [Full Text] [Related]  

  • 23. Metastatic carcinoma of the eye and ocular adnexa.
    Ferry AP
    Int Ophthalmol Clin; 1967; 7(3):615-58. PubMed ID: 5602374
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.
    Zhang F; Yang Y; Smith T; Kau SW; McConathy JM; Esteva FJ; Kuerer HM; Symmans WF; Buzdar AU; Hortobagyi GN; Pusztai L
    Cancer; 2003 Apr; 97(7):1758-65. PubMed ID: 12655533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Our experience with cyclophosphamide, methotrexate and 5-fluorouracil in the postoperative treatment of breast carcinoma].
    Cavallaro V; Grasso F; Minutolo V; Turco F; Narbone G; Consoli A
    Chir Ital; 1982 Apr; 34(2):292-306. PubMed ID: 6896473
    [No Abstract]   [Full Text] [Related]  

  • 26. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
    Gottwald G; Szakolczai I
    Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
    [No Abstract]   [Full Text] [Related]  

  • 27. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
    Bellon JR; Shulman LN; Come SE; Li X; Gelman RS; Silver BJ; Harris JR; Recht A
    Cancer; 2004 Apr; 100(7):1358-64. PubMed ID: 15042668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT
    Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract]   [Full Text] [Related]  

  • 30. [Principles, technic and clinical performance of synchronized radiotherapy].
    Ammon J; Winkel K zum ; Hermann HJ; Janssen B; Schmidt L; Günther W
    Strahlentherapie; 1972 Dec; 144(6):625-34. PubMed ID: 4630820
    [No Abstract]   [Full Text] [Related]  

  • 31. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
    Gül U; Kiliç A
    Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
    [No Abstract]   [Full Text] [Related]  

  • 32. [Internal cancer therapy: cooperative clinical studies. Principles, organization and first results of the Swiss chemotherapy group].
    Praxis; 1967 Dec; 56(50):1691-5. PubMed ID: 5632569
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of metastasizing solid tumors with cyclophosphamide, methotrexate, vincristine and 5-fluorouracil].
    Fritsch H; Castor H; Drings P; Moskwa G
    Verh Dtsch Ges Inn Med; 1973; 79():1373-6. PubMed ID: 4790188
    [No Abstract]   [Full Text] [Related]  

  • 34. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo prediction of drug sensitivity with cancer-seeking isotopes.
    Nathanson L
    Natl Cancer Inst Monogr; 1971 Dec; 34():225-33. PubMed ID: 5140868
    [No Abstract]   [Full Text] [Related]  

  • 36. [Polychemotherapy of bronchial carcinoma].
    Fazio M; Minetto E; Cavallero P; Sartoris S
    Minerva Med; 1970 Jun; 61(46):2567-70. PubMed ID: 5425737
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic drug and hormone therapy after adrenalectomy for advanced breast cancer.
    Keating JL; Yonemoto RH; Byron RL
    Surg Gynecol Obstet; 1968 Sep; 127(3):538-42. PubMed ID: 4969618
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [7 cases of metastasizing tumors of the uvea].
    Meur G; Szyper C; Josse P
    Bull Soc Belge Ophtalmol; 1974; 167():679-92. PubMed ID: 4433964
    [No Abstract]   [Full Text] [Related]  

  • 40. [Combination chemotherapy in advanced carcinoma of the breast].
    Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
    Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.